Physician profile
Nancy Ly
NPI 1295007144
$9,210.12
in general payments reported to CMS, 2019-2025
40 companies · $1,043 in 2025
The $1,043 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,075 · 2020: $684 · 2021: $1,488 · 2022: $978 · 2023: $704 · 2024: $1,239 · 2025: $1,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,985.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,038.33 | 2019-2025 | |
| Medtronic Vascular, INC. | $926.87 | 2019-2020 | |
| Biotronik INC. | $737.14 | 2019-2025 | Biomonitor |
| Merck Sharp & Dohme LLC | $557.48 | 2021-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $531.99 | 2019-2024 | Lifevest |
| Medtronic, INC. | $494.91 | 2021-2025 | Micra, Linq II, Crome Dr Mri Surescan |
| Abbott Laboratories | $455.02 | 2019-2025 | Mitraclip, Navitor |
| Janssen Pharmaceuticals, INC | $383.15 | 2019-2023 | Xarelto |
| Pfizer INC. | $373.21 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $363.32 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $342.96 | 2019-2024 | Watchman Flx |
| Cvrx, INC. | $309.81 | 2021-2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $291.96 | 2019-2024 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $264.74 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $224.96 | 2019-2025 | Evkeeza |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.